Rel Life Sciences lines up Rs 2,500 crore investment – Times of India
MUMBAI: Mukesh Ambani-owned Reliance Life Sciences has earmarked Rs 2,500 crore over the next two years for developing innovative gene...
reliance life sciences
Reliance gets nod to start Covid-19 vaccine trials – Times of India
MUMBAI: Reliance Life Sciences (RLS), part of India's largest conglomerate, is expected to start phase I clinical studies of its...
